EMMANUEL ANTONIO: Open Payments
NPI 1811289432 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 4 payments from 3 companies in 2025. Trend: 2023 $2,662 · 2024 $251 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 2 | $250 |
| Calliditas Therapeutics US Inc. | 1 | $144 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
Products named: Vafseo, TARPEYO, Vanrafia.
Industry payments across DE — which companies pay providers there.
